Minotti G - Search Results

1

Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.

Minotti G, Ronchi R, Salvatorelli E, Menna P, Cairo G. Minotti G, et al. Cancer Res. 2001 Dec 1;61(23):8422-8. Cancer Res. 2001. PMID: 11731422

2

All Eyes on Me, Please: Ocular Palonosetron for the Cancer Patient with Nausea and Vomiting.

Minotti G. Minotti G. J Pharmacol Exp Ther. 2023 Aug;386(2):111-114. doi: 10.1124/jpet.123.001644. J Pharmacol Exp Ther. 2023. PMID: 37460159 No abstract available.

3

A Special Section on Clinical Pharmacology-Editorial.

Minotti G. Minotti G. J Pharmacol Exp Ther. 2023 Aug;386(2):115-116. doi: 10.1124/jpet.123.001743. J Pharmacol Exp Ther. 2023. PMID: 37460160 No abstract available.

4

Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury.

Cairo G, Castrusini E, Minotti G, Bernelli-Zazzera A. Cairo G, et al. Among authors: minotti g. FASEB J. 1996 Sep;10(11):1326-35. doi: 10.1096/fasebj.10.11.8836047. FASEB J. 1996. PMID: 8836047

5

The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium.

Minotti G, Recalcati S, Mordente A, Liberi G, Calafiore AM, Mancuso C, Preziosi P, Cairo G. Minotti G, et al. FASEB J. 1998 May;12(7):541-52. doi: 10.1096/fasebj.12.7.541. FASEB J. 1998. PMID: 9576481

6

Effect of reactive oxygen species on iron regulatory protein activity.

Cairo G, Tacchini L, Recalcati S, Azzimonti B, Minotti G, Bernelli-Zazzera A. Cairo G, et al. Among authors: minotti g. Ann N Y Acad Sci. 1998 Jun 30;851:179-86. doi: 10.1111/j.1749-6632.1998.tb08992.x. Ann N Y Acad Sci. 1998. PMID: 9668619

7

Role of iron in anthracycline cardiotoxicity: new tunes for an old song?

Minotti G, Cairo G, Monti E. Minotti G, et al. FASEB J. 1999 Feb;13(2):199-212. FASEB J. 1999. PMID: 9973309 Review.

8

Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite.

Minotti G, Licata S, Saponiero A, Menna P, Calafiore AM, Di Giammarco G, Liberi G, Animati F, Cipollone A, Manzini S, Maggi CA. Minotti G, et al. Chem Res Toxicol. 2000 Dec;13(12):1336-41. doi: 10.1021/tx000143z. Chem Res Toxicol. 2000. PMID: 11123976

9

Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium.

Minotti G, Saponiero A, Licata S, Menna P, Calafiore AM, Teodori G, Gianni L. Minotti G, et al. Clin Cancer Res. 2001 Jun;7(6):1511-5. Clin Cancer Res. 2001. PMID: 11410484

10

Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue.

Minotti G, Parlani M, Salvatorelli E, Menna P, Cipollone A, Animati F, Maggi CA, Manzini S. Minotti G, et al. Br J Pharmacol. 2001 Nov;134(6):1271-8. doi: 10.1038/sj.bjp.0704369. Br J Pharmacol. 2001. PMID: 11704647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters